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Abstract: Two stability indicating chromatographic methods were proposed for the determination of almotriptan, eletriptan, and 
rizatriptan, in presence of their acid degradation products. The first method is a quantitative densitometric thin layer chromatography. 
The developing systems were; acetonitrile: methanol: dichloromethane: ammonia (10:6:3:1 v/v), ethyl acetate: methanol: ammonia 
(15:4:1 v/v), and methanol: acetonitrile: ammonia (9:4:1 v/v) for almotriptan, eletriptan and rizatriptan respectively. The TLC plates 
were scanned at 235 nm. Linear relationships were obtained over concentration ranges (5–50 µg/spot) for almotriptan and rizatriptan, 
and (5–60 µg/spot) for eletriptan. The second method based on the separation and determination of the studied drugs, using RP-HPLC 
technique. The separation was achieved on C18 Hypersil column, elution was carried out using phosphate buffer pH 3: methanol: 
acetonitrile (2: 1:1 v/v) at flow rate 2 mL/min and UV detection at 235 nm. Linear relationships were obtained over concentration ranges 
(10–200 µg/mL) for almotriptan and eletriptan, and (10–180 µg/mL) for rizatriptan. The chromatographic methods were successfully 
applied for the determination of each of the studied drugs in pure form, tablet form, and in laboratory prepared mixtures with their acid 
degradation products.
Keywords: chromatography, antimigraine, almotriptan, eletriptan, rizatriptan, high performance liquid chromatography, thin layer 
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Introduction
Migraine is described as neurovascular headache,1 
and it is characterized by recurrent attacks of   headache 
which  typically  last  from  4  to  72  hours.  Simple 
analgesics and non steroidal anti-inflammatory drugs 
are effective if taken at the earliest signs of the attack. 
Attacks not responding to simple analgesics or non 
steroidal  anti-inflammatory  drugs  may  be  treated 
with some selective serotonin (5HT1) agonists, eg, 
almotriptan, eletriptan and rizatriptan2 (Fig. 1).
Few methods have been reported for the deter-
mination of almotriptan, eletriptan and rizatriptan in 
pure, pharmaceutical dosage forms and in biologi-
cal fluids. The methods include RP-HPLC using UV 
detector.3–8 Method4,7,8 were used as reference meth-
ods for almotriptan, eletriptan and rizatriptan respec-
tively. They are HPLC methods in which almotriptan 
and  rizatriptan  were  determined  on  hypersil  C18 
column. A mixture of 20% acetonitrile, 80% buffer 
pH 4 and 0.2% triethylamine was used as a mobile 
phase for almotriptan, while the used mobile phase in 
determination of rizatriptan was 20% acetonitrile and 
80% potassium dihydrogen phosphate buffer pH 3.4,8 
Eledetriptan was determined using micro bondaback 
C18  column  and  mobile  phase  of  55%  phosphate 
buffer pH 2.5 and 45% acetonitrile.7 HPLC methods 
using fluorimetric detector were used for the deter-
mination of rizatriptan in presence of its impurities 
or  in  plasma.9–12  HPLC  coupled  with  MS  method 
was  described  for  the  determination  of  rizatriptan 
either in plasma or in serum.13–15 Stability indicating 
method for the determination of mixture of rizatriptan 
and naproxen was established using microemulsion 
electrokinetic chromatography (MEEC).16
experimental
Apparatus
1. Dual  wavelength,  flying  scanning  densitometer, 
Shimadzu CS-9301 PC, Japan.
2. HPLC system, Hewlett Packard (1050 series) with 
quaternary pump, multiple wave length detector, 
auto-sampler, Germany.
3. Hypersil  C18,  5  mm  column,  (25  ×  4  cm)  I.D 
Merck, Darmstadt, Germany.
Materials and reagents
1. Almotriptan working standard (purity 100.16% ±   
0.163%),4 provided by European   Egyptian Pharma. Ind. 
Co., Cairo, Egypt.
2. Almotrip forte tablets, European Egyptian Pharma. 
Ind. Co., Cairo, Egypt, labeled to contain 17.5 mg 
Almotriptan malate.
3. Eletriptan  working  standard  (purity  99.95%  ±   
0.166%),7 provided by Pfizer Co., Cairo, Egypt.
4. Relpax tablets, Pfizer Co. Cairo, Egypt, labeled to 
contain 40 mg eletriptan HBr.
5. Rizatriptan working standard (purity 100.19% ±   
0.315%),8 provided by Epico Co., Cairo, Egypt.
6. Migratec tablet, Epico Co., Cairo, Egypt, labeled 
to contain 10 mg rizatriptan benzoate.
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Figure 1. Chemical structure of rizatriptan, almotriptan and eletriptan.Chromatographic determination of almotriptan, eletriptan and rizatriptan
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  7.   Topiramate working standard (purity 99.84% ±   
0.405%),17 provided  by  Cairo,  Co.,  Cairo,  Egypt, 
used as internal standard.
  8.   Acetonitrile, Methanol, Dichloromethane, Ammonia, 
and ethylacetate, orthophosphoric acid, Hydrochlo-
ric acid, analytical grade (Analar).
  9. Methanol, Acetonitrile, HPLC grade (Analar).
10.    Potassium  dihydrogen  orthophosphate  powder, 
(Elnasr).
Developing systems
For almotriptan: a mixture of acetonitrile:   methanol: 
dichloromethane: ammonia (50:30:15:5 v/v),
For eletriptan: a mixture of ethyl acetate: methanol: 
ammonia (15:4:1 v/v).
For rizatriptan: a mixture of methanol: acetonitrile: 
ammonia (18:8:2 v/v).
Procedure
Preparation of degradation products solutions
An  accurate  weight  of  each  of  almotriptan  or 
  eletriptan or rizatriptan (100 mg) was introduced into 
a 50 mL round bottom flask, and dissolved in least 
amount of acetonitrile. Five mL of   hydrochloric acid 
was added for each flask and the mixture was refluxed 
for five hours. The solution was   evaporated under 
pressure to dryness to constant weight. The residue 
was  weighed  then  dissolved  in    methanol  to  get 
  concentration of 1 mg/mL of degradation products.
Preparation of working standard solutions
For  densitometric  method:  An  accurate  weight 
(200  mg)  of  almotriptan  or  eletriptan,  or  rizatrip-
tan working standards was transferred into a 50 mL 
volumetric  flask.  Acetonitrile  (25  mL)  was  added 
and the solution was shaken in ultrasonic shaker for 
10   minutes, then the volume was completed with the 
same solvent to the mark to form 4 mg/mL working 
standard stock solutions.
For HPLC: Ten mL aliquot of the working standard 
stock solutions was diluted to 100 mL with the same solvent 
to form 0.4 mg/mL working standards stock solutions.
Preparation of internal standard solution
A solution of 100 µg/mL topiramate in acetonitrile 
was prepared.
Preparation of pharmaceutical dosage  
form solutions
Accurate weights of the powdered Almotrip forte, Relpax, 
and Migratec tablets equivalent to 100 mg of almotriptan, 
eletriptan and rizatriptan respectively, were transferred 
into three different 150 mL conical flasks. Acetonitrile 
(40 mL) was added for each flask and the solutions were 
shaken for 15 min. using ultrasonic shaker. The solu-
tions were filtered and the filter papers and the residues 
were washed three times each with 10 mL acetonitrile. 
The combined filtrates and washings were collected into 
three 100 mL volumetric flasks and the volumes were 
completed with the same solvent to produce the pharma-
ceutical dosage form solutions of 1 mg/mL.
Preparation of laboratory prepared mixtures
For densitometric method
Different aliquots of each of almotriptan, eletriptan 
and rizatriptan working standard solution equivalent 
to (2–20 mg) were transferred into three series of 
10 mL volumetric flasks. Aliquots of the degradation 
product  solutions  representing  (10%–90%)  of  the 
intact drugs were added and the volumes were com-
pleted with the same solvent.
For hPLC method
Different aliquots of each of almotriptan, eletriptan 
and  rizatriptan  working  standard  solution  equiva-
lent to (0.1–2 mg) were transferred into three series 
of 10 mL volumetric flasks. Aliquots of the degra-
dation  product  solutions  representing  (10%–90%) 
of the intact drugs were added and1 mL aliquots of 
100  µg/mL  topiramate  internal  standard  solution 
were added to each flask then volumes were com-
pleted using acetonitrile.
general procedure and linearity
Densitometric method
Different  aliquots  of  almotriptan  and  rizatriptan 
stock  standard  solutions  (0.5–5  mL)  equivalent  to 
(2–20 mg), and different aliquots of eletriptan stock 
standard solution (0.5–6 mL) equivalent to (2–24 mg) 
were  transferred  into  three  series  of  10  mL  volu-
metric flasks and the volumes were completed with 
acetonitrile. Twenty five µL aliquots of each solution 
were applied on thin layer chromatographic plates 
20 × 20 cm using The micropipette. The spots were el-Bagary et al
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spaced 2 cm apart from the bottom edge of the plates 
and  the  plates  were  put  in  chromatographic  tanks 
which were previously s  aturated with the specified 
developing systems, for a distance of 16 cm. Plates 
were air dried and the spots were detected under UV 
lamp at 254 nm.
The  drugs  were  scanned  under  the  following 
parameters:
Photo mode: reflection, lane: auto, scan mode: zig-
zag, swing width: 12 cm, beam width: 0.4 × 0.4 cm, 
wavelength: 235 nm.
The resulting outputs, chromatograms, and areas 
under peaks (AUP) were recorded and a calibration 
curve  for  each  drug  representing  the  relationship 
between AUP × 10−3 and its corresponding concen-
tration in µg/25 µL (spot) was plotted. The follow-
ing regression equations were computed to be used in 
calculations of concentrations.
  A = 0.433C + 0.644 r2 = 0.998 for almotriptan  (1)
  A = 0.182C – 0.1635 r2 = 0.997 for eletriptan  (2)
  A = 0.516C – 0.0722 r2 = 0.99 for rizatriptan  (3)
where A is the AUP × 10−3, C is the concentration in 
µg/25 µL(spot), and r is the correlation coefficient.
hPLC method
Different  aliquots  of  almotriptan  and  eletriptan 
stock  standard  solutions  (0.25–5  mL)  equivalent 
to  (0.1–2  mg),  and  different  aliquots  of  rizatrip-
tan  stock  standard  solution  (0.25–4.5  mL)  equiva-
lent  to  (0.1–1.8  mg);  were  transferred  into  three 
series of 10 mL volumetric flasks and1 mL aliquots 
of  100  µg/mL  topiramate  internal  standard  solu-
tion  were  added  to  each  flask  then  volumes  were 
completed using acetonitrile. Twenty µL aliquots of 
each solution were injected to HPLC system using 
auto  sampler  injector.  The  drugs  were  separated 
using Phosphate buffer pH3: methanol: acetonitrile 
(250:125:125 v/v) as a mobile phase at flow rate of 
2 mL/min. and using a Hypersil C18, 5 mm column, 
(25 × 4 cm). The detection is done at 235 nm. The 
ratios between areas under peaks (AUP) of studied 
drugs and those of internal standard were recorded 
and a calibration curve for each drug representing the 
relationship between AUP ratio and its corresponding 
concentration in µg/mL was plotted. The   following 
regression equations were computed to be used in 
calculations of concentrations.
  R = 0.0487C + 0.309 r2 = 0.9998 for almotriptan (4)
  R = 0.1461C − 0.0763 r2 = 0.9992 for eletriptan (5)
  R = 0.0576C − 0.0372 r2 = 0.9994 for rizatriptan (6)
where R is the AUP ratio, C is the concentration in 
µg/mL, and r is the correlation coefficient.
Stability indicating characteristics  
of the TLC densitometric method
Twenty five micro liters of the laboratory prepared 
mixture solutions for each drug and its degradation 
products (prepared for stability indicating characteris-
tics) were applied on TLC plates and the method was 
completed as mentioned under linearity starting from 
“and the plates were put in chromatographic tanks ….”   
The  concentrations  of  the  intact  drugs  in  the  pre-
pared mixtures were calculated using the regression 
equations (1–3).
Stability indicating characteristics  
of the rF-hPLC method
Twenty µL aliquots of each of the laboratory pre-
pared mixture solutions for each drug were injected 
into HPLC system and the procedure was completed 
as mentioned [under General procedure and linearity, 
for HPLC method].
Concentrations of the intact drugs in the prepared 
mixtures  were  calculated  using  the  regression 
  equations 4–6.
Application of proposed methods  
on Almotriptan, eletriptan, and rizatriptan  
in tablet form
Different aliquots of the pharmaceutical   dosage form 
solutions were transferred into three series of 10 mL 
volumetric flasks and the volumes were   completed 
with acetonitrile. The procedures were completed as 
mentioned under General procedure and linearity. 
The same experiment was repeated   applying the stan-
dard addition technique. The c  oncentrations of the 
labeled and added standards of each of   almotriptan, 
rizatriptan and eletriptan were calculated using the 
regression equations 1–6, for each of the studied 
drugs.Chromatographic determination of almotriptan, eletriptan and rizatriptan
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Results and Discussion
Densitometric method
The method was based on the different Rf values of 
the drug of choice and its acid degradation product. 
Complete degradation was achieved by refluxing with 
hydrochloric acid for 5 hours. The Rf values were found 
to be, 0.88, 0.294, and 0.353 for almotriptan, eletriptan 
and rizatriptan respectively, and zero for all acid deg-
radation products. Different developing systems were 
used to obtain well defined spots of cited drugs and better 
separation from acid degradation product. Acetonitrile: 
methanol: dichloromethane: ammonia (50:30:15:5 v/v), 
ethyl  acetate:  methanol:  ammonia  (15:4:1  v/v)  and, 
methanol: acetonitrile: ammonia (18:8:2 v/v) were used 
for almotriptan, eletriptan, and rizatriptan,   respectively. 
The use of ammonia prevents tailing and provides bet-
ter separation.
Linear relationships between AUP × 10–3 and con-
centration were obtained and the regression equations 
were computed (equations 1–3). The method was tested 
for selectivity by analyzing laboratory prepared mix-
tures containing different percentages of the drug with 
its degradation product. The method was found suitable 
for determination of the drug in the presence of 10% up 
to 90% of its degradation product. The mean percentage 
recoveries of the drugs in laboratory prepared mixtures 
were 99.98 ± 1.11, 100.69 ± 0.79, and 100.44 ± 0.82 
for almotriptan, eletriptan and rizatriptan respectively. 
Accuracy of the method was tested and the mean per-
centage accuracy was 99.50 ± 0.90, 100.59 ± 0.53, and 
100.87 ± 0.59 for almotriptan, eletriptan and rizatriptan 
respectively. The method was applied on tablet form 
of  each  drug  and  the  mean  percentage  recoveries 
were100.64 ± 1.07, 100.57 ± 1.28, and 100.42 ± 0.50 for 
almotriptan, eletriptan and rizatriptan respectively. The 
validity of the methods was checked by applying the 
standard addition technique and the resulting percent-
age recoveries of the added authentic were 99.90 ± 0.83, 
100.11 ± 1.28, and 100.02 ± 0.99 almotriptan, eletriptan 
and rizatriptan respectively. Regression data and vali-
dation parameters for the proposed TLC method for the 
determination of AM,EH and RB in presence of their 
degradation products are given in Table 1.
hPLC method
The method was based on the differences in retention 
time values of the drug of choice and its acid degra-
dation  product. Various  mobile  phase  systems  were 
attempted to be used for HPLC separation and sol-
vent  polarity  optimization.  Elution  was  carried  out 
using phosphate buffer pH 3: methanol: acetonitrile 
(2: 1:1 v/v) at flow rate 2 mL/min and UV detection at 
235 nm.   Decreasing the pH to 2 gives bad resolution, 
while increasing the pH to 4 gives tailing of peaks. The 
retention times were found to be, 3.512 min, 3.109 min, 
and 3.845 min for almotriptan, eletriptan and rizatrip-
tan respectively, and, 6.361 min, 6.532 min and 6.057 
for their acid degradation products   respectively. Reten-
tion time was about 1.812 min for the internal standard, 
as shown in Figures 2–4.
Table 1. regression equation and validation parameters for the proposed TLC method for the determination of AM, eh and 
rB in presence of Their degradation products.
Item AM eH RB
rf 0.88 0.29 0.35
Wavelength of detection 235 nm 235 nm 235 nm
Linearity range 5–50 ± µg/spot 5–60 ± µg/spot 5–50 ± µg/spot
regression equation & (r2) Y = 0.433X + 0.644  
r2 = 0.998
Y = 0.182X − 0.164  
r2 = 0.997
Y = 0.516X − 0.072  
r2 = 0.990
Sb 1.13 × 10−2 2.99 × 10−3 8.40 × 10−3
Sa 3.19 × 10−1 9.15 × 10−2 2.48 × 10−1
LOD (µg) 0.314 0.751 0.310
LOQ ( µg) 0.940 2.504 1.034
Confidence limit of the slope 0.4328 ± 9.68 × 10−3 0.1821 ± 1.13 × 10−3 0.516 ± 2.75 × 10−3
Confidence limit of the intercept 0.6443 ± 2.73 × 10−1 0.1635 ± 3.45 × 10−2 0.0722 ± 8.11 × 10−2
Accuracy 99.98 ± 1.11 100.69 ± 0.79 100.44 ± 0.82
Tablets ± SD 100.64 ± 1.07 100.57 ± 1.28 100.42 ± 0.49
Added authentic ± SD 99.9 ± 0.83 100.11 ± 1.28 100.02 ± 0.99
note: Y is the response, X is the concentration (µg/spot), a is the intercept, and b is the slope.el-Bagary et al
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Figure 2. hPLC chromatogram of mixture of almotriptan, degradation product and topiramate as an internal standard.
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Figure 3. hPLC chromatogram of mixture of eletriptan, degradation product and topiramate as an internal standard.
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Figure 4. hPLC chromatogram of mixture of rizatriptan, degradation product and topiramate as an internal standard.Chromatographic determination of almotriptan, eletriptan and rizatriptan
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Table 2. regression equation and validation parameters for the proposed hPLC method for the determination of AM, eh 
and rB in presence of Their degradation products.
Item AM eH RB
retention time 3.512 min 3.109 min 3.845
Wavelength of detection 235 nm 235 nm 235 nm
Linearity range 10–200 µg/mL 10–200 µg/mL 10–180 µg/mL
regression equation & (r2) Y = 0.0487X + 0.309  
r2 = 0.9998
Y = 0.1461X − 0.076  
r2 = 0.9992
Y = 0.0576X − 0.037   
r2=0.9994
Sb 2.14 × 10−4 2.54 × 10−3 5.21 × 10−4
Sa 2.34 × 10−2 2.77 × 10−1 5.47 × 10−2
LOD (µg) 2.66 µg 1.19 µg 1.33 µg
LOQ (µg) 8.85 µg 3.96 µg 4.44 µg
Confidence limit of the slope 0.0487 ± 6.76 × 10−5 0.1461 ± 2.35 × 10−3 0.576 ± 3.85 × 10−4
Confidence limit of the intercept 0.309 ± 7.4 × 10−3 0.0763 ± 2.57 × 10−1 0.0372 ± 4.04 × 10−2
Accuracy 100.62 ± 0.91 100.62 ± 0.42 99.92 ± 1.22
Tablets ± SD 100.64 ± 1.07 100.28 ± 0.83 100.51 ± 0.99
Added authentic ± SD 99.9 ± 0.83 100.02 ± 0.99 99.59 ± 1.076
note: Y is the response, X is the concentration (µg/mL), a is the intercept, and b is the slope.
Table 3. Statistical comparison between results of analysis of the studied drugs applying the proposed methods and 
  reference methods.4,7,8
statistical item Drug studded Reference method HpLc proposed method TLc proposed method
n Almotriptan 5 6 6
Mean 100.31 100.62 99.49
SD 1.03 0.91 0.89
variance 1.06 0.83 0.81
Se 0.46 0.37 0.37
LOD 1.19 0.94
LOQ 3.96 0.32
Student t test 0.32 (1.833)* 0.86 (1.833)*
F ratio 1.28 (5.19)* 1.32 (5.19)*
n eletriptan 5 6 6
Mean 99.68 100.62 100.19
SD 0.95 0.42 1.26
variance 0.90 0.18 1.58
Se 0.65 0.17 0.51
LOD (µg) 0.75
LOQ (µg) 2.51
Student t test  0.93 (1.833)* 0.38 (1.833)*
F ratio 1.24 (5.19)* 1.26 (5.19)*
n rizatriptan 5 6 6
mean 100.66 99.92 100.87
SD 0.74 1.23 0.59
variance 0.55 1.49 0.34
Se 0.33 0.50 0.24
LOD (µg) 0.31
LOQ (µg) 1.04
Student t test 0.74 (1.833)* 0.33 (1.833)*
F ratio 2.75 (6.62)* 1.59 (5.19)*el-Bagary et al
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Linear relationships between AUP ratios and con-
centration  were  obtained  and  the  regression  equa-
tions were computed (equations 4–6). The method 
was  tested  for  selectivity  by  analyzing  laboratory 
prepared  mixtures  containing  different  percentages 
of the drug with its degradation product. The method 
was found suitable for determination of the drug in 
the presence of 10% up to 90% of its degradation 
product. The mean percentage recoveries of the drugs 
in laboratory prepared mixtures were 99.44 ± 0.76, 
100.05 ± 1.02, and 100.45 ± 0.97 for almotriptan, 
eletriptan  and  rizatriptan  respectively.  Accuracy 
of the method was tested and the mean percentage 
accuracy  was  100.62  ±  0.91,  100.62  ±  0.42,  and 
99.92 ± 1.22 for almotriptan, eletriptan and rizatriptan 
  respectively. The method was applied on tablet form 
of each drug and the mean percentage recoveries were 
100.32 ± 1.31, 100.03 ± 0.60, and 100.03 ± 0.85 for 
almotriptan,  eletriptan  and  rizatriptan  respectively. 
The validity of the methods was checked by apply-
ing the standard addition technique and the resulting 
percentage  recoveries  of  the  added  authentic  were 
99.73 ± 1.36, 100.02 ± 1.00, and 99.59 ± 1.08 for 
almotriptan,  eletriptan  and  rizatriptan  respectively. 
Regression  data  and  validation  parameters  for  the 
proposed HPLC method for the determination of AM, 
EH and RB in presence of Their degradation products 
are given in Table 2.
Statistical comparison between the results obtained 
by  the  suggested  densitometric,  and  RP—HPLC 
methods with the reference methods4,7,8 of analysis of 
the cited drugs was carried out and no significant dif-
ference,18  between  them  was  indicated,  as  shown  in 
Table 1.
Statistical comparison between the result of analy-
sis of the proposed TLC and HPLC methods and the 
reference methods4,7,8 shows no significant   differences. 
As shown in Table 3.
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